ZURICH / LONDON (IT BOLTWISE) – Roche shares recorded a significant price decline on the SIX Swiss Exchange on Thursday morning. Despite positive news from a breast cancer study and the FDA’s release of a new drug, the stock lost value. However, analysts remain optimistic and expect a stable dividend for the coming year.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
Roche shares fell 1.7 percent on Thursday morning and were quoted at CHF 275.80 on the SIX Swiss Exchange. The price temporarily fell to CHF 271.10 after opening at CHF 273.40. A total of 71,924 shares changed hands, indicating increased trading activity.
On March 12, 2025, Roche shares reached their 52-week high at a price of CHF 313.80, which is 13.78 percent above the current price. The 52-week low was marked on April 9, 2025 at CHF 231.90. A further price loss of 15.92 percent would cause the share price to fall back to this level.
Roche plans to give its shareholders a dividend of CHF 9.90 per share, after paying out CHF 9.70 in the previous year. Analysts value the share on average at CHF 276.00, which is close to the current price. The next balance sheet presentation is expected on January 29, 2026, while the profit and sales figures for the fourth quarter of 2026 are scheduled to be published on February 4, 2027.
The recent positive results from a breast cancer study with the drug Giredestrant and the FDA’s approval of Gazyva could not prevent the share price from falling. Despite these successes, the stock remains under pressure, which could be due to challenges in the market environment and competition from new technologies such as Illumina’s gene sequencing.
*Order an Amazon credit card with no annual fee with a credit limit of 2,000 euros! a‿z
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Roche shares: price decline despite positive study results”.